Clinical Trial Update: Evaluation of STARgraft AV for Hemodialysis Access [NA]

View source ↗

Summary

A completed clinical trial evaluating STARgraft AV for hemodialysis access sponsored by Healionics Corporation in End-stage renal disease patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• STARgraft AV

Snippet

Sponsor: Healionics Corporation | Conditions: End Stage Renal Disease | NA | Status: COMPLETED